Shares of Medidata Solutions, Inc. (NASDAQ:MDSO) have earned an average recommendation of “Buy” from the fifteen brokerages that are currently covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $83.54.

A number of research firms have recently commented on MDSO. KeyCorp restated a “buy” rating and issued a $86.00 price target on shares of Medidata Solutions in a research report on Sunday, September 17th. Royal Bank Of Canada began coverage on Medidata Solutions in a research report on Tuesday, September 19th. They issued a “sector perform” rating and a $82.00 price target on the stock. Zacks Investment Research upgraded Medidata Solutions from a “sell” rating to a “hold” rating in a research report on Wednesday, September 20th. SunTrust Banks, Inc. restated a “buy” rating and issued a $92.00 price target on shares of Medidata Solutions in a research report on Friday, October 27th. Finally, Wells Fargo & Company dropped their price target on Medidata Solutions from $83.00 to $80.00 and set a “market perform” rating on the stock in a research report on Friday, October 27th.

COPYRIGHT VIOLATION WARNING: This article was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this article on another publication, it was copied illegally and republished in violation of United States and international copyright legislation. The original version of this article can be read at https://www.watchlistnews.com/medidata-solutions-inc-mdso-receives-consensus-recommendation-of-buy-from-analysts/1722512.html.

In other Medidata Solutions news, EVP Michael I. Otner sold 10,000 shares of Medidata Solutions stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $70.88, for a total value of $708,800.00. Following the sale, the executive vice president now owns 80,674 shares of the company’s stock, valued at approximately $5,718,173.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert Taylor sold 5,000 shares of Medidata Solutions stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $71.39, for a total value of $356,950.00. Following the completion of the sale, the director now directly owns 49,372 shares in the company, valued at approximately $3,524,667.08. The disclosure for this sale can be found here. Insiders sold a total of 225,944 shares of company stock worth $15,568,274 in the last ninety days. 5.80% of the stock is owned by corporate insiders.

Institutional investors and hedge funds have recently made changes to their positions in the business. Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new stake in Medidata Solutions in the 2nd quarter valued at approximately $601,000. Russell Investments Group Ltd. boosted its holdings in Medidata Solutions by 80.5% in the 2nd quarter. Russell Investments Group Ltd. now owns 28,574 shares of the company’s stock valued at $2,235,000 after purchasing an additional 12,743 shares in the last quarter. State of Wisconsin Investment Board purchased a new stake in Medidata Solutions in the 2nd quarter valued at approximately $7,674,000. LS Investment Advisors LLC boosted its stake in shares of Medidata Solutions by 49.5% during the 2nd quarter. LS Investment Advisors LLC now owns 4,947 shares of the company’s stock worth $387,000 after acquiring an additional 1,637 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund purchased a new stake in shares of Medidata Solutions during the 2nd quarter worth approximately $925,000. 97.52% of the stock is currently owned by institutional investors.

Medidata Solutions (NASDAQ:MDSO) traded up $0.36 on Thursday, hitting $70.25. The stock had a trading volume of 277,900 shares, compared to its average volume of 545,568. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.29 and a quick ratio of 3.37. Medidata Solutions has a twelve month low of $47.77 and a twelve month high of $85.92. The firm has a market capitalization of $4,110.00, a PE ratio of 84.21, a P/E/G ratio of 4.35 and a beta of 1.77.

Medidata Solutions (NASDAQ:MDSO) last posted its earnings results on Thursday, October 26th. The company reported $0.33 EPS for the quarter, topping the Zacks’ consensus estimate of $0.31 by $0.02. Medidata Solutions had a return on equity of 11.54% and a net margin of 7.84%. The business had revenue of $140.08 million for the quarter, compared to analysts’ expectations of $141.27 million. During the same quarter in the previous year, the firm earned $0.28 earnings per share. The business’s revenue was up 16.7% compared to the same quarter last year. equities research analysts forecast that Medidata Solutions will post 0.77 earnings per share for the current fiscal year.

About Medidata Solutions

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Analyst Recommendations for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.